Impact of Exercise on "Invisible" Symptoms and Quality of Life in Multiple Sclerosis Individuals
Launched by UNIVERSITY OF RIJEKA · Dec 6, 2018
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
This study will include individuals with multiple sclerosis including all MS types with EDSS from 0-8, who will be practicing at the Multiple Sclerosis Association in Rijeka for a period of 2 month, 2 times a week for 60 minutes per exercise (total 16h).
Participants will be randomly selected into 2 groups: MS individuals that will exercise - group (MSE), with related control group of individuals who will not exercise) (MSC).
In addition, a group of healthy control subjects without MS (HCE) will also exercise and be evaluated after the study with related control individuals who will not e...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals with multiple sclerosis (EDSS 0-8)
- • Ambulatory and non-ambulatory (in wheelchairs)
- Exclusion Criteria:
- • Individuals with contraindications for exercising
- • Individuals with multiple sclerosis with EDSS over 8
About University Of Rijeka
The University of Rijeka, a prominent academic institution in Croatia, is dedicated to advancing medical research and clinical studies through its various faculties and research centers. With a strong emphasis on innovation and collaboration, the university actively engages in clinical trials aimed at improving healthcare outcomes and fostering scientific advancements. Leveraging its multidisciplinary approach, the University of Rijeka is committed to adhering to the highest ethical standards and regulatory guidelines, ensuring the integrity and reliability of its research initiatives while contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rijeka, , Croatia
Patients applied
Trial Officials
Tanja Grubić Kezele, PhD, MD
Principal Investigator
University of Rijeka
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials